Table 1.
Descriptive statistics from a sample of employed patients with cancer who received assistance from a national non-profit, stratified by self-reported race/ethnicity (Oct – Nov 2019).
| Self-reported Race/Ethnicity | |||||
|---|---|---|---|---|---|
| Non-Hispanic White | Non-Hispanic Black | Hispanic/Latino | Other1 | Not reported | |
| N=619 | 392 | 110 | 56 | 33 | 28 |
| Gender | |||||
| Female | 323 (82.4%) | 94 (85.5%) | 45 (80.4%) | 25 (75.8%) | 23 (82.1%) |
| Male | 69 (17.6%) | 16 (14.5%) | 11 (19.6%) | 8 (24.2%) | 5 (17.9%) |
| Marital status | |||||
| Married or living with partner | 182 (46.4%) | 25 (22.7%) | 27 (48.2%) | 17 (51.5%) | 11 (39.3%) |
| Single | 93 (23.7%) | 59 (53.6%) | 18 (32.1%) | 11 (33.3%) | 10 (35.7%) |
| Divorced, widowed, or separated | 117 (29.8%) | 26 (23.6%) | 11 (19.6%) | 5 (15.2%) | 7 (25.0%) |
| Full vs part-time employment | |||||
| Part-time | 77 (19.6%) | 14 (12.7%) | 6 (10.7%) | 2 (6.1%) | 7 (25.0%) |
| Full-time | 315 (80.4%) | 96 (87.3%) | 50 (89.3%) | 31 (93.9%) | 21 (75.0%) |
| Educational Attainment | |||||
| Two year college degree or less | 220 (56.1%) | 70 (63.6%) | 37 (66.1%) | 15 (45.5%) | 15 (53.6%) |
| College degree (BA/BS) or more | 153 (39.0%) | 34 (30.9%) | 19 (33.9%) | 14 (42.4%) | 12 (42.9%) |
| Other or not reported | 19 (4.8%) | 6 (5.5%) | 0 (0.0%) | 4 (12.1%) | 1 (3.6%) |
| Insurance coverage at the time of diagnosis | |||||
| Private | 270 (68.9%) | 81 (73.6%) | 44 (78.6%) | 24 (72.7%) | 19 (67.9%) |
| Public (Medicare, Medicaid, Military) | 72 (18.4%) | 15 (13.6%) | 4 (7.1%) | 8 (24.2%) | 5 (17.9%) |
| Uninsured | 28 (7.1%) | 11 (10.0%) | 5 (8.9%) | 1 (3.0%) | 2 (7.1%) |
| Other or not reported | 22 (5.6%) | 3 (2.7%) | 3 (5.4%) | 0 (0.0%) | 2 (7.1%) |
| Age at diagnosis | |||||
| 19-40 years old | 57 (14.5%) | 28 (25.5%) | 12 (21.4%) | 7 (21.2%) | 4 (14.3%) |
| 41-60 years old | 222 (56.6%) | 73 (66.4%) | 31 (55.4%) | 22 (66.7%) | 18 (64.3%) |
| 61 years or older | 113 (28.8%) | 9 (8.2%) | 13 (23.2%) | 4 (12.1%) | 6 (21.4%) |
| Time since first diagnosis | |||||
| Within the last 12 months | 49 (12.5%) | 21 (19.1%) | 8 (14.3%) | 9 (27.3%) | 4 (14.3%) |
| 1 to 4 years ago | 192 (49.0%) | 56 (50.9%) | 32 (57.1%) | 15 (45.5%) | 12 (42.9%) |
| 5 or more years ago | 151 (38.5%) | 33 (30.0%) | 16 (28.6%) | 9 (27.3%) | 12 (42.9%) |
| Cancer Stage | |||||
| Stage 1 or 2 | 146 (37.2%) | 46 (41.8%) | 17 (30.4%) | 10 (30.3%) | 7 (25.0%) |
| Stage 3 or 4 | 163 (41.6%) | 46 (41.8%) | 28 (50.0%) | 17 (51.5%) | 16 (57.1%) |
| Unknown | 83 (21.2%) | 18 (16.4%) | 11 (19.6%) | 6 (18.2%) | 5 (17.9%) |
| Cancer Site | |||||
| Solid tumor2 | 294 (75.0%) | 90 (81.8%) | 46 (82.1%) | 25 (75.8%) | 21 (75.0%) |
| Blood3 | 70 (17.9%) | 16 (14.5%) | 5 (8.9%) | 4 (12.1%) | 5 (17.9%) |
| Not reported | 28 (7.1%) | 4 (3.6%) | 5 (8.9%) | 4 (12.1%) | 2 (7.1%) |
1Other includes Asian (n=17), American Indian/Alaskan Native (n<10), Middle Eastern (n<10), Native Hawaiian/Other Pacific Islander (n<10), Caribbean Islander (n<10), and mixed race (n<10). Counts less than 10 suppressed for confidentiality.
2Solid tumor cancers include breast (n=366), prostate (n=27), colorectal (n=22), gynecologic (n=12), lung (n=12), head and neck (n<10), bone (n<10), bladder (n<10), gastrointestinal (n<10), liver (n<10), endocrine (n<10), sarcoma (n<10), skin (n<10), thyroid (n<10). Counts less than 10 suppressed for confidentiality.
3Blood cancers include myeloma (n=74), Non-Hodgkin’s or Hodgkin lymphoma (n=15), leukemia (n=11).